Researchers at the RIKEN Advanced Science Institute have demonstrated that a technique for tagging and profiling proteins can be used to accurately classify anti-cancer drugs based on the molecules they target. The technique, developed in collaboration with a researcher at the University of Tsukuba, promises to accelerate the process of proteomic profiling and contribute to more effective drug discovery.
While essential for effective treatment, our understanding of the complex relationship between drugs and their molecular targets is far from complete. Drug efficacy is thus low, and drugs are often accompanied by dangerous side effects. Targeted cancer therapies, which act by interfering with specific molecules contributing to tumor growth, can bring therapeutic benefits to certain patients, yet are not free of these problems. Solving them depends on connecting drugs to their molecular targets, a task complicated by the huge variety of proteins and complexity of drug-target networks.
In recent years, the field of proteomics has produced powerful techniques that simplify this task by accurately identifying proteins and their interactions. The research team used one of these techniques, two-dimensional difference gel electrophoresis (2D-DIGE), to analyze and compare changes of protein expression levels in HeLa cancer cells treated with 19 well-known anti-cancer agents. The method successfully classified compounds of different structures but sharing molecular target(s), while revealing that compounds previously reported to inhibit the same process in fact were clustered into different groups, highlighting differences in underlying interaction mechanisms.
Described in the journal Chemistry and Biology, the findings broaden the scope of proteomic profiling by enabling researchers to characterize specific compounds in terms of how they interact with biomolecules. While refining the drug discovery process, this advance also contributes to minimizing side-effects, potentially supporting the future development of safer and more effective anticancer drugs.
For more information, please contact:Dr. Hiroyuki Osada
One step closer to reality
20.04.2018 | Max-Planck-Institut für Entwicklungsbiologie
The dark side of cichlid fish: from cannibal to caregiver
20.04.2018 | Veterinärmedizinische Universität Wien
University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.
Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.
Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.
Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...
Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.
The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...
Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.
Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...
In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...
13.04.2018 | Event News
12.04.2018 | Event News
09.04.2018 | Event News
20.04.2018 | Physics and Astronomy
20.04.2018 | Interdisciplinary Research
20.04.2018 | Physics and Astronomy